Senz Oncology has recruited the first subject for the debut human trial of oral chemotherapeutic candidate VAL-1000 in patients with acute leukaemia. [ + ]

Australian researchers have developed a statistical model that will help identify people with a high risk of bowel and endometrial cancer. [ + ]

Biota (ASX:BTA) will add a $4.2m tax credit for the December quarter to its bottom line after receiving the funds through the R&D Tax Incentive. [ + ]

The ability of a world-renowned ocean scientist to inform the media and the wider community about his work has won him a prestigious international award. [ + ]

Bioniche (ASX:BNC) said its licensing partner has called off a phase III trial of Urocidin, a bladder cancer treatment, due in part to slow recruitment. [ + ]

Data from early studies of CSL's (ASX:CSL) lipoprotein-based treatment candidate show its potential in reducing the risk of recurrent heart attacks. [ + ]

Quest Diagnostics is evaluating using a biomarker-based blood test for colorectal cancer developed by Clinical Genomics, the CSIRO and the Flinders Centre for Innovation in Cancer. [ + ]

A Monash University team has won a $1 million grant to develop an inhalable oxytocin treatment for post-partum haemorrhage, a leading cause of death in emerging markets. [ + ]

A workshop for the development of natural medicines from the Muricidae family of sea snail will be conducted at Southern Cross University (SCU) this week. [ + ]

Deborah Middleton, Senior Veterinary Pathologist at CSIRO, explains how she and her team developed the groundbreaking vaccine for the deadly Hendra virus. [ + ]

AusBiotech yesterday announced the election of a new member to its board of directors following the national biotechnology organisation’s annual general meeting, held at the national conference in Melbourne. [ + ]

Vaxxas, a UniQuest start-up established in 2011 to commercialise the Nanopatch vaccine delivery system based on research from The University of Queensland (UQ), has won the Janssen 2012 AusBiotech Emerging Company Award. [ + ]

EMD Millipore and Sistemic are jointly developing a monitoring methodology utilising Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells in EMD Millipore’s Mobius CellReady platform. [ + ]

Cancer researcher, Professor Mark Shackleton, has been awarded the Science Minister’s Prize for Life Scientist of the Year for his work understanding the nature of cancer. [ + ]

Pharmaceutical industry and policy expert, Michelle Burke, has joined the AusBiotech board, as Dr Paul Walton and Dr Peter Isdale AM depart. [ + ]